{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:30:09Z","timestamp":1762853409275,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.oret.2019.09.014","type":"journal-article","created":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T01:30:25Z","timestamp":1569979825000},"page":"e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Re: Mansukhani et\u00a0al: Fluorescein Angiography in Retinopathy of Prematurity: Comparison of Infants Treated with Bevacizumab to Those with Spontaneous Regression (Ophthalmol Retina. 2019;3:436-443)"],"prefix":"10.1016","volume":"4","author":[{"given":"Marco H.","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2104-9239","authenticated-orcid":false,"given":"Domenico","family":"Lepore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2019.09.014_bib1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.oret.2019.01.016","article-title":"Fluorescein angiography in retinopathy of prematurity: comparison of infants treated with bevacizumab to those with spontaneous regression","volume":"3","author":"Mansukhani","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2019.09.014_bib2","first-page":"1902","article-title":"Development and evaluation of reference standards for image-based telemedicine diagnosis and clinical research studies in ophthalmology","volume":"2014","author":"Ryan","year":"2014","journal-title":"AMIA Annu Symp Proc AMIA Symp"},{"key":"10.1016\/j.oret.2019.09.014_bib3","doi-asserted-by":"crossref","unstructured":"Fierson WM, American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, et\u00a0al. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018;142:e20183061.","DOI":"10.1542\/peds.2018-3061"},{"key":"10.1016\/j.oret.2019.09.014_bib4","first-page":"1","article-title":"Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings","volume":"125","author":"Lepore","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2019.09.014_bib5","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.oret.2019.06.017","article-title":"Retinopathy of prematurity reactivated 28 months after injection of ranibizumab","volume":"3","author":"Ji","year":"2019","journal-title":"Ophthalmol Retina"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653019305743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653019305743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:27:13Z","timestamp":1762853233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653019305743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2468653019305743"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2019.09.014","relation":{},"ISSN":["2468-6530"],"issn-type":[{"type":"print","value":"2468-6530"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re: Mansukhani et\u00a0al: Fluorescein Angiography in Retinopathy of Prematurity: Comparison of Infants Treated with Bevacizumab to Those with Spontaneous Regression (Ophthalmol Retina. 2019;3:436-443)","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2019.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2019.01.016","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}